Podium Presentation Clinical Outcome

24.2.5 - Athletes Given Capsular Repair Have Successful Outcomes: A Propensity-Matched Analysis With Minimum 2-Year Follow-Up

Presentation Topic
Clinical Outcome
Date
15.04.2022
Lecture Time
11:36 - 11:45
Room
Potsdam 3
Session Type
Free Papers
Speaker
  • P. Padilla (Des Plaines, US)
Authors
  • A. Jimenez (Des Plaines, US)
  • B. Domb (Des Plaines, US)
  • M. Lee (Des Plaines, US)
  • D. Radwanski (Des Plaines, US)
  • J. Owens (Des Plaines, US)
  • B. Saks (Des Plaines, US)
  • D. Maldonado (Des Plaines, US)
  • A. Lall (Des Plaines, US)
  • T. Harris (Des Plaines, US)
  • P. Sabetian (Des Plaines, US)
  • P. Padilla (Des Plaines, US)
Disclosure
Financial interests: Amplitude, Arthrex, ATI, Breg, DJO Global, Kauffman Foundation, MAKO Surgical, Medacta, Medwest, Orthomerica, Pacira Pharmaceuticals, Stryker Affiliations: American Hip Institute, Hinsdale Orthopaedics, North Shore Surgical Suites,

Abstract

Purpose

To compare minimum 2-year patient reported outcome scores (PROs) and return to sport (RTS) between high-level athletes who undergo primary hip arthroscopy with a capsular repair and high-level athletes undergoing primary hip arthroscopy with an unrepaired interportal capsulotomy.

Methods and Materials

Data on all professional, collegiate, and high-school athletes who underwent primary hip arthroscopy between February 2012 and December 2018 were collected. Athletes were divided into 2 groups based on whether they received a capsular repair (R) or an unrepaired interportal capsulotomy (UR). Minimum 2-year PROs were collected for the Nonarthritic Hip Score (NAHS), Hip Outcome Score-Sports Specific Subscale (HOS-SSS), visual analog scale (VAS) for pain, and RTS status. R athletes were propensity-score matched to UR athletes for comparison.

Results

A total of 53 UR athletes (53 hips) with an average follow-up time of 36.5 ± 10.2 months were propensity-score matched to 84 R athletes (84 hips) with an average follow-up time of 41.3 ± 9.4 months. R athletes demonstrated significantly greater magnitude of improvement from preoperative to minimum 2-year postoperative scores for NAHS (P = 0.01), HOS-SSS (P = 0.001), and VAS (P = 0.01). Further, R athletes demonstrated significantly higher rates of achieving MCID for NAHS (73.8% vs 54.7%, P = 0.034) and HOS-SSS (65.5% vs 37.7%, P = 0.003) compared to UR athletes. RTS rates were higher in R athletes compared to the UR athletes, but this did not reach statistical significance (80.6% vs 65.9%, P = 0.170).

athlete capsule.flowchart.pngathlete capsule.sports.png

Conclusion

High-level athletes who undergo primary hip arthroscopy and capsular repair demonstrated significantly greater magnitude of improvement in PROs (NAHS, HOS-SSS, and VAS) compared to a control group athletes with an unrepaired interportal capsulotomy.

Collapse